More recently, a pilot study from The Cancer Genome Atlas has demonstrated that ADC values obtained from clinical DWI correlated with survival in patients with IDH-mutant and IDH wild-type gliomas regardless of WHO grade, suggesting a potential usefulness of quantitative ADC estimates as a prognostic marker to enhance risk stratification in brain gliomas [37]. The gene discussed is IDH2; the disease is glioma.